IRFI-165
UNII 0N85EM7V9B

Substance Identification & Data

This profile provides standardized clinical and technical data for Irfi-165, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0N85EM7V9B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 191349-26-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0N85EM7V9B
CAS Registry Number
191349-26-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IRFI-165
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H18N4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QRZLMPANXOGORV-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n12c(c(nc3ccccc13)NC4CCCC4)ncc2C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Irfi-165. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

IRFI-165

Systematic Nomenclature

4-(CYCLOPENTYLAMINO)-1-METHYLIMIDAZO(1,2-A)QUINOXALINE
IMIDAZO(1,2-A)QUINOXALIN-4-AMINE, N-CYCLOPENTYL-1-METHYL-